Mark Elliott
Impact in
- Neurology top 10%
- Botulinum Toxin and Related Neurological Disorders
- Neurological disorders and treatments
-
- Hereditary Neurological Disorders
Papers in
- Neurology 12
- Botulinum Toxin and Related Neurological Disorders 12
- Neurological disorders and treatments 11
-
- Hereditary Neurological Disorders 7
- Co-authors
- David Clayton (1 shared paper)Erik K. Insko (1 shared paper)Matthew Beard (11 shared papers)Ravinder Reddy (3 shared papers)Johannes Krupp (5 shared papers)Raquel E. Gur (1 shared paper)Kosha Ruparel (2 shared papers)David R. Roalf (2 shared papers)
- Journals
- Toxins (4 papers)Toxicon (3 papers)PLoS ONE (1 paper)Schizophrenia Research (1 paper)Frontiers in Aging Neuroscience (1 paper)
- Partner nations
- United StatesFranceSweden
In The Last Decade
Mark Elliott
18 papers receiving 394 citations
Peers
Comparison fields: 5 of 66
- Neurology 150
- Cellular and Molecular Neuroscience 128
- Radiology, Nuclear Medicine and Imaging 116
- Biophysics 22
- Pathology and Forensic Medicine 57
Countries citing papers authored by Mark Elliott
This map shows the geographic impact of Mark Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Elliott more than expected).
Fields of papers citing papers by Mark Elliott
This network shows the impact of papers produced by Mark Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Elliott. The network helps show where Mark Elliott may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 64 | |
| 2 | 2012 | 51 | |
| 3 | 2002 | 50 | |
| 4 | 2010 | 47 | |
| 5 | 2012 | 44 | |
| 6 | 2019 | 33 | |
| 7 | 2018 | 29 | |
| 8 | 2018 | 24 | |
| 9 | 2018 | 16 | |
| 10 | 2017 | 12 | |
| 11 | 2024 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2018 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2018 | 4 | |
| 16 | 2016 | 2 | |
| 17 | Methods for improved quantitative accuracy in magnetic resonance imaging and spectroscopy | 2000 | 1 |
| 18 | 2018 | 1 | |
| 19 | 2025 | 0 |
About Mark Elliott
Mark Elliott is a scholar working on Neurology, Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Cognitive Neuroscience, having authored 19 papers that have together received 398 indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (12 papers), Neurological disorders and treatments (11 papers), Hereditary Neurological Disorders (7 papers), Advanced MRI Techniques and Applications (4 papers), Spine and Intervertebral Disc Pathology (2 papers), Cancer Treatment and Pharmacology (2 papers), Lanthanide and Transition Metal Complexes (2 papers) and Cellular transport and secretion (2 papers). The work is most often cited by research in Neurology (150 citations), Cellular and Molecular Neuroscience (128 citations), Radiology, Nuclear Medicine and Imaging (116 citations), Biophysics (22 citations) and Pathology and Forensic Medicine (57 citations). Mark Elliott has collaborated with scholars based in United States, France and Sweden. Frequent co-authors include David Clayton, Erik K. Insko, Matthew Beard, Ravinder Reddy, Johannes Krupp, Raquel E. Gur, Kosha Ruparel, David R. Roalf, Ragini Verma and Ruben C. Gur. Their work appears in journals such as Toxins, Toxicon, PLoS ONE, Schizophrenia Research and Frontiers in Aging Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.